Related Experiment Video
Updated: Aug 4, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.2K
Deep Multi-Modal Discriminative and Interpretability Network for Alzheimer's Disease Diagnosis
IEEE Transactions on Medical Imaging
|April 4, 2023
Summary
This study introduces a new deep learning method for Alzheimer's disease (AD) diagnosis using multi-modal data. The novel Deep Multi-modal Discriminative and Interpretability Network (DMDIN) identifies key brain regions for improved diagnostic accuracy.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Medical Imaging Analysis
Background:
- Alzheimer's disease (AD) diagnosis benefits from multi-modal data fusion.
- Existing fusion methods often overlook sample structure and biomarker identification.
- High-order feature extraction in deep learning hinders biomarker discovery.
Purpose of the Study:
- To propose a novel deep learning method, DMDIN, for Alzheimer's disease diagnosis.
- To align samples in a discriminative common space for enhanced diagnosis.
- To identify significant brain regions (ROIs) and improve model interpretability.
Main Methods:
- Reconstructing modalities using multilayer perceptron (MLP) for hierarchical representation.
- Embedding structural information via shared self-expression coefficients with diagonal block constraints.
- Utilizing generalized canonical correlation analysis (GCCA) for a discriminative common space.
- Employing knowledge distillation for interpretability and capturing brain region influence.
Main Results:
- The proposed DMDIN method outperforms several state-of-the-art methods in Alzheimer's disease diagnosis.
- The network successfully aligns samples, grouping similar categories and separating dissimilar ones.
- Interpretability is enhanced, allowing for the identification of influential brain regions.
Conclusions:
- DMDIN offers a novel approach to multi-modal fusion for Alzheimer's disease diagnosis.
- The method effectively extracts discriminative information and enhances model interpretability.
- DMDIN shows significant potential for identifying biomarkers and improving diagnostic accuracy in AD.

